MARKSANS PHARMA LTD.
Market Cap.(`)
|
7561.04 Cr.
|
P/BV
|
4.33
|
Book Value (`)
|
38.51
|
52 Week High/Low ( ` )
|
186/71
|
FV/ML
|
1/1
|
P/E(X)
|
28.39
|
Book Closure
|
07/06/2023
|
EPS (`)
|
5.88
|
Div Yield (%)
|
0.30
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 1849.62 | 1480.12 | 1368.37 | 1129.33 | 987.33 |
Other Operating Revenues | 2.52 | 10.72 | 7.81 | 4.87 | 12.74 |
Total Operating Revenues | 1852.14 | 1490.84 | 1376.18 | 1134.21 | 1000.07 |
| | | | | |
Other Income | 59.31 | 41.85 | 6.69 | 0.33 | 4.62 |
Total Revenue | 1911.45 | 1532.69 | 1382.88 | 1134.54 | 1004.69 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 612.97 | 540.67 | 419.76 | 371.33 | 412.06 |
Purchase Of Stock-In Trade | 314.78 | 163.25 | 311.57 | 120.60 | 105.85 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -6.39 | 12.90 | -136.28 | 52.95 | -19.90 |
Employee Benefit Expenses | 239.37 | 220.30 | 197.32 | 168.42 | 159.07 |
Finance Costs | 9.13 | 8.45 | 7.99 | 8.75 | 9.66 |
Depreciation And Amortisation Expenses | 51.85 | 44.78 | 36.15 | 26.66 | 22.80 |
Other Expenses | 352.09 | 294.84 | 244.20 | 228.66 | 210.85 |
Total Expenses | 1573.80 | 1285.18 | 1080.71 | 977.36 | 900.38 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 337.65 | 247.51 | 302.16 | 157.17 | 104.31 |
| | | | | |
Profit/Loss Before Tax | 337.65 | 247.51 | 302.16 | 157.17 | 104.31 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 71.57 | 57.10 | 66.69 | 32.41 | 23.59 |
Deferred Tax | 1.10 | 3.59 | -3.07 | 4.47 | 1.00 |
Tax For Earlier Years | -0.33 | 0.01 | 0.00 | -0.45 | -0.72 |
Total Tax Expenses | 72.33 | 60.70 | 63.63 | 36.42 | 23.87 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 265.32 | 186.81 | 238.54 | 120.75 | 80.44 |
| | | | | |
Profit/Loss From Continuing Operations | 265.32 | 186.81 | 238.54 | 120.75 | 80.44 |
| | | | | |
Profit/Loss For The Period | 265.32 | 186.81 | 238.54 | 120.75 | 80.44 |
| | | | | |
Minority Interest | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 |
Consolidated Profit/Loss After MI And Associates | 266.31 | 186.81 | 238.54 | 120.75 | 80.44 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 6.41 | 4.51 | 5.76 | 2.86 | 1.87 |
Diluted EPS (Rs.) | 6.41 | 4.51 | 5.76 | 2.86 | 1.87 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 10.17 | 10.23 | 4.09 | 29.50 | 4.44 |
Preference Share Dividend | 0.00 | 0.00 | 0.00 | 5.00 | 0.00 |